61 studies found for:    Blood Transfusion | Open Studies | NIH, U.S. Fed
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Transfusion of Prematures Trial
Conditions: Infant, Newborn, Diseases;   Infant, Extremely Low Birth Weight;   Infant, Small for Gestational Age;   Bronchopulmonary Dysplasia (BPD);   Anemia
Interventions: Procedure: Liberal Cell Transfusion;   Procedure: Restricted red cell transfusion
2 Recruiting Duration of Red Blood Cell Storage Prior to Transfusion and Non-Transferrin-Bound Iron
Condition: Iron, Blood Level Abnormal
Interventions: Biological: Transfusion of blood randomized to 1 week of storage;   Biological: Transfusion of blood randomized to 2 weeks of storage;   Biological: Transfusion of blood randomized to 3 weeks of storage;   Biological: Transfusion of blood randomized to 4 weeks of storage;   Biological: Transfusion of blood randomized to 5 weeks of storage;   Biological: Transfusion of blood randomized to 6 weeks of storage
3 Recruiting PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions
Condition: Iron, Abnormal Blood Level
Interventions: Biological: Transfusion of red blood cells;   Biological: Infusion of albumin/saline
4 Recruiting Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage
Conditions: Subarachnoid Hemorrhage;   Vasospasm
Intervention: Biological: Red blood cell transfusion
5 Unknown  Frozen Red Blood Cell Transfusions in Trauma Patients
Condition: Transfusion
Intervention: Biological: Red Blood Cells
6 Recruiting Study of Transfusion-Transmitted Infections
Condition: Virus Disease
7 Recruiting Optimized Erythropoietin (EPO) Treatment
Condition: Neonatal Anemia
Interventions: Drug: Epoetin Alpha;   Drug: Biotinylated Red Blood Cells
8 Recruiting Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
Conditions: Thrombocytopenia;   Alloimmune Platelet Refractoriness
Intervention: Drug: Eculizumab
9 Recruiting Improving White Blood Cell Collection From Healthy Donors
Conditions: Blood Donor;   Leukocyte Transfusion;   Granulocyte Colony-Stimulation Factor;   Blood Component Removal
Interventions: Drug: Filgrastim (G-CSF);   Drug: Dexamethasone
10 Recruiting Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets
Condition: Thrombocytopenia
Interventions: Biological: CPP;   Biological: LSP
11 Unknown  Simplified Severe Sepsis Protocol-2 (SSSP-2) in Zambia
Conditions: Sepsis;   Severe Sepsis;   Tuberculosis
Interventions: Other: Simplified severe sepsis protocol;   Other: Usual care
12 Not yet recruiting Topical TXA in Spine Trauma Surgery
Conditions: Spinal Injuries;   Spinal Deformity
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
13 Recruiting AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Condition: Traumatic Shock
Intervention: Drug: Vasopressin
14 Unknown  Simplified Severe Sepsis Protocol in Zambia
Conditions: Sepsis;   Severe Sepsis
Intervention: Other: Simplified Severe Sepsis Protocol
15 Recruiting Establishment of a Perinatal Database and a Bank of Biological Materials
Conditions: Preterm Labor;   Preterm Birth;   Pregnancy
16 Recruiting Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia
Conditions: Peripheral Blood Stem Cell Transplantation;   Anemia, Sickle Cell;   Graft-Versus-Host Disease;   Sirolimus (Rapamune );   Alemtuzumab (Campath )
Interventions: Procedure: PBMC Transplant;   Drug: Alemtuzumab (Campath  );   Drug: Sirolimus (Rapamune  );   Drug: Cyclophosphamide (Cytoxan  );   Procedure: Low Dose Irradiation
17 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment
Intervention: Drug: Eltrombopag
18 Recruiting Treatment of Hemochromatosis
Condition: Hemochromatosis
19 Recruiting Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia;   Chronic Myelomonocytic Leukemia;   de Novo Myelodysplastic Syndrome;   Previously Treated Myelodysplastic Syndrome
Interventions: Biological: Epoetin Alfa;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide
20 Recruiting Massive Iron Deposit Assessment
Conditions: Iron Overload;   Excessive Body Iron Burden
Interventions: Device: R2*-UTE;   Device: R2*-GRE;   Procedure: Liver biopsy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years